EQR
53
-7
A
39
-4
TEL
69
-5
MUR
48
3
OXY
52
-3
TDC
73
2
ZION
67
-4
ADSK
70
-4
NWL
50
-6
GWW
69
-9
ECL
59
-3
NI
70
-3
FOX
59
2
PLD
51
-5
PSA
55
-3
APA
25
5
AAL
59
2
NTRS
55
-5
EL
20
2
DE
39
3
EQR
53
-7
A
39
-4
TEL
69
-5
MUR
48
3
OXY
52
-3
TDC
73
2
ZION
67
-4
ADSK
70
-4
NWL
50
-6
GWW
69
-9
ECL
59
-3
NI
70
-3
FOX
59
2
PLD
51
-5
PSA
55
-3
APA
25
5
AAL
59
2
NTRS
55
-5
EL
20
2
DE
39
3
Financhill
Back

Edgewise Therapeutics Stock Predictions

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Buy
58

EWTX
Edgewise Therapeutics

Last Price:
31.60
Seasonality Move:
66.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.

Edgewise Therapeutics Stock Forecast

  • Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 149.5% based on the past 3 years of stock performance.
  • Edgewise Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Edgewise Therapeutics Stock Undervalued?
    The current Edgewise Therapeutics [EWTX] share price is $32.87. The Score for EWTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • EWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Edgewise Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 149.5% based on the past 3 years of stock performance.

Edgewise Therapeutics Stock Rating

Buy
58
Edgewise Therapeutics (EWTX) is a Buy

Is Edgewise Therapeutics overpriced?

  • Edgewise Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Edgewise Therapeutics Stock Price History

Is EWTX stock going to rise?

  • The current trend is moderately bearish and EWTX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
edgewisetx.com

52-Week Data

52-Week High:
38.12
52-Week Low:
5.93

Prediction Charts

Market Cap:
3.11B
Price in USD:
32.87
Volume:
517.68K
Beta:
0.15

Technical Analysis

SMA50:
28.88
SMA100:
23.95
SMA200:
20.72
52-Wk Change:
404.92%

Stock Predictions

  • Is Edgewise Therapeutics stock public?
    Yes, Edgewise Therapeutics is a publicly traded company.
  • What is the Edgewise Therapeutics stock quote today?
    The Edgewise Therapeutics stock price is 32.87 USD today.
  • How to buy Edgewise Therapeutics stock online?
    You can buy Edgewise Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-28 35.41 34.02 35.55 33.94
Oct-29 33.88 34.44 34.88 33.86
Oct-30 34.06 33.32 34.20 33.22
Oct-31 33.00 33.54 34.09 32.32
Nov-1 33.71 34.00 34.12 33.48
Nov-4 33.94 34.48 35.14 33.07
Nov-5 34.58 35.94 36.09 33.64
Nov-6 37.00 36.61 37.29 35.66
Nov-7 36.75 35.43 37.00 34.39
Nov-8 34.96 36.38 36.70 34.79
Nov-11 37.00 35.33 38.12 35.21
Nov-12 35.24 35.22 35.99 34.00
Nov-13 35.45 33.26 35.79 33.00
Nov-14 32.40 32.87 33.99 32.40

Edgewise Therapeutics Earnings

Edgewise Therapeutics Earnings Report: Per Share Edgewise Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Edgewise Therapeutics Forecast Revenue Growth

Edgewise Therapeutics Stock Analysis: Historical quarterly revenues per share for Edgewise Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.35 per share.

* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.